AdaptHealth Corp.

AHCO Healthcare Medical Devices

Revenue
+10.9%
EPS
−758.8%
Free cash flow
−23.6%
Total debt
+6.85%

Quarter to September 2026, against a year earlier

7.33 0.08 −1.08%
Market cap
$1.0B
P/E
0.0×
Fwd P/E
−4.6×
Dividend yield
—
F-score
4/9
Altman Z
0.91
Beneish M
−3.26
Dividend safety
n/a

AdaptHealth Corp. (AHCO) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, AdaptHealth Corp. (AHCO) trades at a EV/Sales of 0.8×. Over the past ten years it has ranged from 0.0× (December 2019) to 4.4× (April 2021); the current reading is higher than 22% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 0.9× (8.63%)
FY2024 1.0× 1.39%
FY2023 1.0× (39.93%)
FY2022 1.6× (23.51%)
FY2021 2.1× (15.90%)
FY2020 2.5× 129.01%
FY2019 1.1× —
FY2018 0.0× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 0.8× (22.81%)
Jun 2026 1.0× (2.17%)
Mar 2026 1.0× 12.32%
Dec 2025 0.9× (5.30%)
27 more quarters

Against its own ten years

Low 0.0× High 4.4×
Ten-year median 1.1×
Current reading's percentile 4

EV/Sales against peers

Company EV/Sales
AHCO AdaptHealth Corp. 0.8×
QDEL QuidelOrtho Corporation compare 1.4×
BVS Bioventus Inc. compare 1.6×
IART Integra LifeSciences Holdings Corporation compare 1.6×
KIDS OrthoPediatrics Corp. compare 3.1×
BBNX Beta Bionics, Inc. compare 3.8×
SIBN SiBone compare 4.4×
CBLL CeriBell, Inc. compare 8.3×
IRMD iRadimed Corporation compare 11.4×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on AHCO